Anal Sac Tumors and Anal Sac Cancer in Dogs
Evidence-informed veterinary guide to symptoms, diagnosis, staging, treatment options, and long-term management for pet owners and veterinary teams.
Last updated: 2026-01-16 · Reviewed by: TCMVET Integrative Oncology Editorial Team
Anal sac carcinoma (apocrine gland anal sac adenocarcinoma, AGASACA) is a locally invasive malignant tumor in dogs with a high potential for early spread to regional lymph nodes. Clinical signs commonly relate to mechanical obstruction from the primary mass and/or enlarged metastatic lymph nodes, and some dogs develop paraneoplastic hypercalcemia (high blood calcium), which can contribute to increased thirst and urination and may affect overall health. Many patients benefit from a multi-modal plan that prioritizes local control when feasible and long-term systemic management and monitoring.
- Early signs can resemble routine anal gland irritation
- Constipation and straining can occur due to pelvic canal narrowing or rectal compression
- Staging matters because regional lymph node involvement is common
- Blood calcium is important, especially with increased thirst and urination
- Persistent constipation or straining deserves a rectal exam and discussion of imaging
- A firm perianal lump, especially one-sided, warrants sampling (FNA/biopsy)
- Check calcium on bloodwork if thirst/urination increases
- Long-term management often focuses on progression control and quality of life
Scope note: This page covers symptoms, diagnosis, staging, treatment overview, and monitoring. It does not provide drug dosing or individualized protocols—those should be determined by your veterinary team.
Owner Action Summary (For Families Facing Anal Sac Cancer)
With suspected or confirmed anal sac carcinoma (AGASACA), the most helpful next step is not guessing—it’s a fast, structured plan: confirm the diagnosis, stage the disease (lymph nodes + chest), and check calcium. These three steps determine the safest treatment options and the dog’s comfort plan.
Many dogs live meaningful time with good quality of life when the plan focuses on local control when feasible, systemic disease management, and consistent monitoring. Early staging and calcium management can make a real difference.
What Are Anal Sac Tumors in Dogs
Anal sac tumors are abnormal growths arising in or around the anal sacs. They can be benign or malignant. The most clinically important malignant form is anal sac carcinoma, also called apocrine gland anal sac adenocarcinoma. These tumors can invade locally and may spread to regional lymph nodes.
Because anal sac tumors can mimic routine “anal gland issues,” a physical exam and appropriate sampling are essential for a reliable diagnosis.
Clinical Snapshot (Veterinary Reference)
Why Anal Sac Carcinoma Is Often Missed Early
Early disease may look like common anal gland trouble. Mild scooting, licking, or subtle stool changes can be the only signs. Some tumors grow deeper in the pelvis and may not be obvious until they enlarge, affect lymph nodes, or contribute to obstruction.
Symptoms Owners Notice Most Often
Pooping changes that build slowly
- Taking longer to defecate
- Squatting for a long time, crying, or straining
- Constipation or irregular stool patterns over weeks to months
Local signs around the anus
- Firm lump near one side of the anus
- Scooting or excessive licking
- Discomfort when sitting
Walking and stamina changes
- Hind-leg weakness, shorter walks, difficulty with stairs
- Taking longer to stand up, sitting down more often
Some dogs with anal sac carcinoma develop paraneoplastic hypercalcemia. Hypercalcemia can increase thirst and urination and may be clinically significant, so bloodwork including calcium is an important part of evaluation and monitoring.
Later-stage whole-body changes
- Reduced appetite, weight loss, lethargy
- Faster breathing, coughing if there is lung involvement
Symptoms at a Glance
A fast visual guide to common owner-noticed changes. Any single sign can be non-specific, but patterns and persistence matter.
Straining to poop
Long squatting, crying, pushing, or taking much longer than usual.
Constipation or irregular stool
Every day becomes every 2–3 days. Stool may alternate between hard and soft.
Firm lump near the anus
Often one-sided, firm, and less “movable” than a simple swelling.
Scooting or licking
Can resemble routine anal gland irritation in early disease.
Hind-leg weakness
Shorter walks, harder stairs, slower to stand. Sometimes related to pelvic space-occupying effects.
More drinking and urination
May be associated with hypercalcemia in some cases and deserves bloodwork.
These signs do not confirm cancer, but they do justify a rectal exam and discussion of imaging.
Typical Care Pathway
A simplified educational roadmap, not an official staging system.
How this cancer commonly spreads
Primary tumor (anal sac area)
Local pressure can affect stool passage and sitting comfort.
Regional lymph nodes
Common first site to evaluate on ultrasound or CT.
Distant sites (e.g., lungs)
Chest imaging helps screen for spread in advanced disease.
Diagnosis and Staging
Because anal sac carcinoma can spread early, diagnosis usually includes confirmation of the mass and staging to evaluate regional lymph nodes and distant sites.
- Rectal examination and careful palpation of anal sacs
- Fine needle aspiration (FNA) or biopsy of the mass
- Abdominal ultrasound or CT to evaluate regional lymph nodes
- Chest radiographs (or CT) to screen for lung spread
- Blood tests including calcium
If constipation or straining persists or recurs, ask your veterinarian about a rectal exam and imaging. Earlier confirmation and staging often give more options for long-term management.
Differential Diagnosis
Several non-cancerous conditions can mimic anal sac carcinoma in early stages. Differentiation requires physical examination and cytologic or histologic confirmation.
- Anal sac infection, abscess, or cyst
- Perianal (hepatoid) gland adenoma
- Perianal fistula or chronic dermatitis
- Rectal polyp or rectal mass
- Perianal soft tissue tumors (e.g., lipoma, mast cell tumor)
Staging and Treatment Decision Framework
Treatment planning for anal sac carcinoma is guided by tumor biology, disease stage, and the dog’s overall health status. Veterinary oncology teams typically evaluate the following factors:
- Size and local invasiveness of the primary tumor
- Regional lymph node involvement (imaging and sampling)
- Presence or absence of distant metastasis (thoracic imaging)
- Calcium status and kidney function
- Surgical resectability and feasibility of radiation therapy
- Owner goals and quality-of-life priorities
Based on these findings, treatment intent may range from curative-intent local control to long-term disease management and symptom-focused care.
Treatment Options
Surgery
When feasible, surgery is considered for local control of the primary tumor and may include management of affected regional lymph nodes depending on staging and surgical assessment.
Radiation therapy
Radiation may be used for local control, especially when complete surgical margins are not achievable or when disease is not fully resectable.
Chemotherapy
Chemotherapy may be considered depending on stage, lymph node involvement, and overall oncology assessment.
Targeted therapy (toceranib / Palladia)
Toceranib (Palladia) is a targeted therapy used in some dogs to help slow progression and support systemic control of measurable disease. Responses vary, and it is typically part of an overall oncology plan rather than a guaranteed or curative single treatment.
Monitoring Checklist
A practical checklist families can use alongside their veterinary team.
Owner FAQ: Anal Sac Tumors and Anal Sac Cancer in Dogs
Short, extractable answers written for pet owners and designed to align with the page’s structured data.
What is anal sac carcinoma in dogs?
Anal sac carcinoma (apocrine gland anal sac adenocarcinoma) is a malignant tumor arising from anal sac tissue. It can invade locally and commonly involves regional lymph nodes, so staging is important.
How can I tell an anal gland infection from an anal sac tumor?
Infections often improve with expression and treatment. Tumors are more likely to feel firm and fixed, cause ongoing constipation or straining, and persist or recur despite routine anal gland care. Sampling (FNA/biopsy) is needed to confirm.
What are the earliest signs owners usually notice?
Early signs may include straining to poop, taking longer to defecate, recurring constipation, scooting or licking, and discomfort when sitting. A mass may be small or not obvious early on.
My dog has a lump near the anus. What should I do first?
Schedule a veterinary exam and request a rectal exam. Your veterinarian may recommend cytology (FNA) or biopsy and imaging to evaluate regional lymph nodes and chest.
Why does anal sac cancer cause constipation and straining?
The tumor and/or enlarged lymph nodes can narrow the pelvic canal or compress the rectum, making stool passage difficult. Persistent constipation in an older dog should be evaluated.
Why do some dogs drink more water and pee more?
Some dogs with anal sac carcinoma develop paraneoplastic hypercalcemia. Hypercalcemia can increase thirst and urination and may be clinically significant, so calcium should be checked on bloodwork.
What tests are commonly used to diagnose and stage anal sac tumors?
Common tests include rectal exam, FNA/biopsy of the mass, abdominal ultrasound or CT for lymph nodes, chest radiographs or CT for lung screening, and bloodwork including calcium.
Has my dog already metastasized if a lymph node is enlarged?
Not always. Lymph nodes can enlarge from inflammation, but this cancer commonly spreads to regional nodes. Sampling and/or imaging helps clarify whether metastasis is present.
What are the main treatment options for anal sac carcinoma?
Plans may include surgery and/or radiation for local control, plus systemic options such as chemotherapy or targeted therapy depending on stage. Supportive care for pain, bowel function, hydration, and appetite is also important.
What is Palladia and what should owners realistically expect?
Palladia (toceranib) is a targeted therapy used in some dogs to help slow progression. Responses vary, and it is typically part of an overall oncology plan rather than a guaranteed or curative single treatment.
What is the prognosis and how long can dogs live with anal sac cancer?
Survival varies by stage, lymph node involvement, hypercalcemia, and local control feasibility. Earlier detection and a structured long-term plan often support better quality of life.
What does long-term management usually include?
Long-term management often includes rechecks, bloodwork (including calcium), imaging as recommended, symptom control for comfort and bowel function, and ongoing adjustments to support quality of life.
When is it an emergency?
Seek urgent care if your dog cannot pass stool, has severe straining or pain, becomes weak or collapses, stops eating completely, vomits repeatedly, or appears dehydrated.
What information helps a veterinary team personalize a plan?
Helpful details include body weight, diagnosis/pathology, staging results (lymph nodes and chest imaging), calcium and kidney values, current medications and schedule, stool pattern and straining severity, appetite, and overall energy level.
Final Summary
- What it is: Anal sac carcinoma (AGASACA) is a locally invasive malignant tumor in dogs with a strong tendency to spread early to regional lymph nodes.
- Why it matters: Early signs often resemble routine anal gland disease, but lymph node metastasis and hypercalcemia can significantly affect treatment and prognosis.
- What good care looks like: The best outcomes usually come from a multi-modal plan that combines local control when feasible with systemic disease management, symptom support, and structured monitoring.
Bottom line: Persistent straining, constipation, or a firm one-sided perianal lump should never be dismissed as simple anal gland trouble. Early diagnosis and staging often provide more options for long-term disease control and quality-of-life support.
References (peer-reviewed, DOI links)
Each reference includes a DOI resolver link so the source can be verified and accessed via the publisher or indexed databases.
- Rosol TJ, et al. Identification of Parathyroid Hormone-related Protein in Canine Apocrine Adenocarcinoma of the Anal Sac. Vet Pathol. 1990. DOI: 10.1177/030098589002700203
- Gröne A, et al. Dependence of humoral hypercalcemia of malignancy on parathyroid hormone-related protein expression in canine anal sac apocrine gland adenocarcinoma. Vet Pathol. 1998. DOI: 10.1177/030098589803500503
- Potanas CP, et al. Surgical excision of anal sac apocrine gland adenocarcinomas with and without adjunctive chemotherapy in dogs. JAVMA. 2015. DOI: 10.2460/javma.246.8.877
- Skorupski KA, et al. Outcome and prognostic factors for dogs with early-stage anal sac adenocarcinoma treated with surgery alone. JAVMA. 2018. DOI: 10.2460/javma.253.1.84
- London C, et al. Preliminary evidence for biologic activity of toceranib phosphate in solid tumours. Vet Comp Oncol. 2012. DOI: 10.1111/j.1476-5829.2011.00275.x
- Elliott JW. Response and outcome following toceranib phosphate treatment for stage four anal sac apocrine gland adenocarcinoma in dogs: 15 cases. JAVMA. 2019. DOI: 10.2460/javma.254.8.960
- Urie BK, et al. Evaluation of expression and function of VEGFR2, PDGFR-α/β, KIT, and RET in canine apocrine gland anal sac adenocarcinoma. BMC Vet Res. 2012. DOI: 10.1186/1746-6148-8-67
- Repasy AB, et al. Canine Apocrine Gland Anal Sac Adenocarcinoma: A Review. Top Companion Anim Med. 2022. DOI: 10.1016/j.tcam.2022.100682
If your dog has persistent straining/constipation or a firm one-sided perianal lump, assume it could be more than “anal glands” until proven otherwise: confirm with sampling, stage lymph nodes + chest, and check calcium—these steps drive the safest treatment and comfort plan.